Cell & Gene Therapy East Asia 2025

25th September 2025 - September 26, 2025

Cell & Gene Therapy East Asia 2025 will unite top experts from South Korea, Japan, China, and Taiwan to explore the latest breakthroughs in regenerative medicine.

The conference will spotlight innovations in gene-modified cell therapies, scalable manufacturing, and regulatory frameworks to drive commercial success in cell and gene therapy. As a key platform for collaboration across biopharma, academia, and CDMOs, the event aims to bridge research with clinical and commercial applications—driving the future of precision medicine in East Asia.

CGT East Asia (CGTEA) 2025: Advancing the Next Frontier of Regenerative Medicine
Returning after a successful 2023 edition, CGT East Asia 2025 will be held on 25–26 September 2025 at Songdo Convensia, Incheon, South Korea.

The event unites top leaders from South Korea, Japan, China, and Taiwan to explore breakthroughs in gene editing, cell therapy, and personalised medicine. With a focus on clinical translation, scalable manufacturing, and regulatory pathways, CGTEA is a must-attend for biopharma, academia, and CDMOs. Co-located with Biologics Manufacturing Korea and ADC Asia Congress, it offers unmatched networking across the biopharma value chain. Korea is rising — CGTEA is where the future connects.

To receive a 15% discount! Please use the code “BA15” at checkout.

More Info